Internal Medicine, Nephrology · Loma Linda, CA
NPI
1669496832
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
25865 Barton Rd, Suite 101
Loma Linda, CA, 92354
Phone (909) 558-3636
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
717 services
Medicare patients, 2024
166
Average age 59
Drug cost, 2024
$1.5M
1,990 prescriptions
Company payments, 2025
$111K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael Villicana was code 99215 (office e&m - established), 243 times for 91 patients. In total Rafael Villicana billed 717 services in 6 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 243 | 91 | $136.40 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 205 | 100 | $13.13 | $2,691 |
| 99233 Hospital E&M - Subsequent | Facility | 185 | 47 | $93.51 | $17K |
| 99214 Office E&M - Established | Office | 47 | 44 | $76.43 | $3,592 |
| 99223 Hospital E&M - Initial | Facility | 36 | 32 | $137.79 | $4,960 |
By year: 2022 $97K for 875 services; 2023 $63K for 540 services; 2024 $62K for 717 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael Villicana prescribed most often to Medicare patients was Prednisone, with 306 prescriptions and refills. In total Rafael Villicana wrote 1,990 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 306 | 416 | 63 | $932 |
| Famotidine Generic | 121 | 125 | 23 | $443 |
| Pantoprazole Sodium Generic | 98 | 107 | 18 | $480 |
| Lokelma Sodium Zirconium Cyclosilicate | 95 | 96 | 17 | $72K |
| Farxiga Dapagliflozin Propanediol | 82 | 96 | 12 | $60K |
| Tamsulosin Hcl Generic | 75 | 95 | 14 | $537 |
| Carvedilol Generic | 72 | 72 | 13 | $184 |
| Cinacalcet Hcl Generic | 71 | 95 | 13 | $12K |
| Nifedipine Er Nifedipine | 66 | 77 | 13 | $1,061 |
| Losartan Potassium Generic | 66 | 96 | 14 | $310 |
| Tacrolimus Generic | 57 | 69 | 13 | $2,752 |
| Nulojix Belatacept | 52 | 54 | Under 11 | $93K |
| Amlodipine Besylate Generic | 49 | 66 | 18 | $88.49 |
| Methenamine Hippurate Generic | 43 | 58 | 11 | $2,943 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 38 | 38 | Under 11 | $431K |
Brand drugs: 463 claims; generic drugs: 1,456 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael Villicana $111K ($111K in general payments such as food, travel and fees) from 13 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $45K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 45 | $45K |
| Alexion Pharmaceuticals, Inc. AZN | 25 | $30K |
| Amgen Inc. AMGN | 23 | $10K |
| Sanofi-Aventis U.S. LLC SNY | 13 | $9,880 |
| Travere Therapeutics, Inc. TVTX | 7 | $8,499 |
| Argenx US, Inc. ARGX | 2 | $6,600 |
| Veloxis Pharmaceuticals, Inc. | 7 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $156 |
| Genzyme Corporation SNY | 1 | $150 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $71.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.